Lidocaine toxicity misinterpreted as a stroke
- PMID: 20046253
- PMCID: PMC2791737
Lidocaine toxicity misinterpreted as a stroke
Abstract
For more than 50 years lidocaine has been used to treat ventricular arrhythmias. Neurologic dysfunction, manifested as a stroke, occurred acutely in an 87-year-old woman after she had been administered repeated doses of lidocaine, a lidocaine infusion, then an intravenous amiodarone infusion for ventricular tachycardia. This was ultimately diagnosed as lidocaine toxicity with a serum lidocaine level of 7.9 mg/L (1.5-6.0 mg/L). We discuss lidocaine toxicity and risk factors leading to its development, which include particularly hepatic dysfunction, cardiac dysfunction, advanced age and other drug administration.
References
-
- State-specific mortality from sudden cardiac death--United States, 1999. MMWR Morb Mortal Wkly Rep. 2002;51:123–6. - PubMed
-
- ECC Committee, Subcommittees and Task Forces of the American Heart Association American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005;2005;112(24 Suppl):IV1–203. - PubMed
-
- Walker IA, Slovis CM. Lidocaine in the treatment of status epilepticus. Acad Emerg Med. 1997;4:918–22. - PubMed
-
- Jonville AP, Barbier P, Blond MH, et al. Accidental lidocaine overdosage in an infant. J Toxicol Clin Toxicol. 1990;28:101–6. - PubMed